Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin S Iversen

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
NPJ Genomic Medicine|June 6, 2022
An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significanceEdwin S Iversen, Gary Lipton, Steven N Hart, et al.
Genetics & Epigenetics|December 17, 2014
Maternal stress, preterm birth, and DNA methylation at imprint regulatory sequences in humansAdriana C Vidal, Sara E Benjamin Neelon, Ying Liu, et al.
Frontiers in Genetics|March 31, 2012
Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian CarcinomaLinda E Kelemen, Qinggang Wang, Irina Dinu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2008
Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancerThomas A Sellers, Yifan Huang, Julie Cunningham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcomeAndrew Berchuck, Edwin S Iversen, Jingqin Luo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 6, 2019
Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer RiskBrett M Reid, Jennifer B Permuth, Y Ann Chen, et al.
Frontiers in Genetics|August 15, 2012
Germline copy number variation and ovarian cancer survivalBrooke L Fridley, Prabhakar Chalise, Ya-Yu Tsai, et al.
The Journal of Biological Chemistry|February 16, 2019
Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotationVanessa C Fernandes, Volha A Golubeva, Giuliano Di Pietro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2006
Characterization of BRCA1 and BRCA2 mutations in a large United States sampleSining Chen, Edwin S Iversen, Tara Friebel, et al.
Nature Communications|April 9, 2026
Combining multiplexed assays of variant effect for enhanced BRCA2 variant classificationChunling Hu, Sounak Sahu, Wenan Chen, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
NPJ Genomic Medicine|June 6, 2022
An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significanceEdwin S Iversen, Gary Lipton, Steven N Hart, et al.
Genetics & Epigenetics|December 17, 2014
Maternal stress, preterm birth, and DNA methylation at imprint regulatory sequences in humansAdriana C Vidal, Sara E Benjamin Neelon, Ying Liu, et al.
Frontiers in Genetics|March 31, 2012
Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian CarcinomaLinda E Kelemen, Qinggang Wang, Irina Dinu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2008
Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancerThomas A Sellers, Yifan Huang, Julie Cunningham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcomeAndrew Berchuck, Edwin S Iversen, Jingqin Luo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 6, 2019
Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer RiskBrett M Reid, Jennifer B Permuth, Y Ann Chen, et al.
Frontiers in Genetics|August 15, 2012
Germline copy number variation and ovarian cancer survivalBrooke L Fridley, Prabhakar Chalise, Ya-Yu Tsai, et al.
The Journal of Biological Chemistry|February 16, 2019
Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotationVanessa C Fernandes, Volha A Golubeva, Giuliano Di Pietro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2006
Characterization of BRCA1 and BRCA2 mutations in a large United States sampleSining Chen, Edwin S Iversen, Tara Friebel, et al.
Nature Communications|April 9, 2026
Combining multiplexed assays of variant effect for enhanced BRCA2 variant classificationChunling Hu, Sounak Sahu, Wenan Chen, et al.
Pageof 11